Iopamiron

Iopamidol, the active ingredient in Iopamiron, is a non‑ionic iodinated contrast media presented as a sterile injectable solution for intra‑arterial and intravenous use. It enhances X‑ray attenuation, allowing clearer visualization of vascular and tissue structures during diagnostic imaging procedures such as angiography and computed tomography.

GNH USA supplies Iopamiron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, clinics and imaging centres worldwide, providing reliable global distribution and regulatory support.

Iopamiron is used as an iodinated contrast agent in radiographic procedures that require enhanced vascular and tissue visualization. - Angiography: improves delineation of blood vessels for diagnostic and interventional procedures. - Computed tomography (CT) imaging: provides high‑contrast enhancement of organs and vessels to aid lesion detection. - Cardiac catheterization: facilitates clear visualization of coronary arteries and cardiac chambers during interventional cardiology. - Peripheral vascular imaging: enhances imaging of limb arteries and veins for assessment of occlusive disease.

Iopamiron may be associated with a range of adverse reactions, most of which are mild and transient, while rare events can be serious.

Common Side Effects: - Warm sensation or flushing: brief feeling of heat during injection. - Metallic taste: transient alteration of taste perception. - Nausea or vomiting: mild gastrointestinal upset. - Injection site pain: localized discomfort at the infusion site.

Serious or Rare Side Effects: - Severe allergic reaction or anaphylaxis: rapid onset of respiratory distress, rash and hypotension. - Contrast‑induced nephropathy: acute decline in renal function, especially in patients with pre‑existing kidney disease. - Cardiopulmonary arrest: rare life‑threatening event requiring immediate resuscitation.

Prior to using Iopamiron, several precautions should be observed to minimize risk and ensure patient safety. - Renal function assessment: evaluate serum creatinine and eGFR before administration. - Iodine allergy review: confirm no history of severe reactions to iodinated contrast. - Use lowest effective dose: tailor volume to the specific imaging study. - Monitor vital signs: observe patient during and after injection for hypersensitivity. - Avoid in uncontrolled hyperthyroidism: iodine load may exacerbate thyroid hormone release. - Store at ambient temperature: keep in original container, protect from moisture and light.

Iopamiron can interact with certain medications, altering safety or efficacy.

Major Interactions (Avoid): - Metformin: risk of lactic acidosis in renal impairment; consider temporary discontinuation. - ACE inhibitors or ARBs: may increase risk of contrast‑induced nephropathy; assess renal function. - Iodine‑containing drugs (e.g., amiodarone): can potentiate thyroid dysfunction.

Moderate Interactions (Monitor Closely): - Diuretics: may exacerbate volume depletion and affect renal handling of contrast. - Beta‑blockers: can mask hypotensive responses during contrast administration.